Publication | Closed Access

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Tumor ImmunologyUrologyMedicineMetronomic TherapyImmunologyImmune Checkpoint InhibitorDose-escalation TrialProstatic DiseaseImmunotherapyOncologyCell TransplantationPhase 1